Matthew R. Baldwin M.D., M.S.

Herbert Irving Assistant Professor of Medicine

Bio

Dr. Baldwin is board-certified pulmonary and critical care physician and clinical investigator with a Masters in Biostatistics. Dr. Baldwin’s research aims to improve critical illness survivorship and spans three areas of study.

(1) Epi-translational research to endophenotype acute respiratory failure survivors and elucidate the mechanisms of post-ICU frailty as therapeutic targets for improving physical recovery. He has identified frailty subtypes in acute respiratory failure survivors, and discovered that aging-related plasma biomarkers of inflammation, neuro-endocrinopathy, and muscle mitochondrial myopathy are potential therapeutic targets for post-ICU interventions.

(2) He conducts clinical and epidemiologic research with a focus on clinical risk prediction modeling and health disparities outcomes.

(3) He has helped develop novel palliative care interventions for mechanical ventilation patients, such as chaplain-led communication-board-guided spiritual care.

During the COVID-19 pandemic, he worked with data scientists, radiologists, and immunologists to help create the Columbia COVID critical care database, and to publish studies in COVID related to the efficacy of hydroxychloroquine, heterogeneity of critical care outcomes, obesity and the risk of acute respiratory failure, immune responses of resiliency in COVID ARDS, and post-COVID pulmonary fibrosis.

EDUCATION AND TRAINING

Undergraduate:
B.S. in Biology with Honors, Boston College, Boston, MA
Medical School:
Columbia University, College of Physicians and Surgeons, New York, NY
Residency:
Internal Medicine, Johns Hopkins Hospital, Baltimore, MD
Fellowship(s):
Pulmonary and Critical Care Medicine, Columbia University Medical Center, New York, NY
Post-Doctoral Research Pulmonary and Critical Care Medicine, Columbia University Medical Center, New York, NY

SELECTED HONORS AND AWARDS

2017

Herbert Irving Assistant Professor of Medicine at CUMC

2016-

Co-leader, Geriatrics section, Integrating Special Populations Research, Clinical and Translational Science Award, Columbia University Irving Institute for Clinical and Translational Medicine, New York, NY

2016

Faculty Research Fellowship, Columbia Aging Center, Columbia University Mailman School of Public Health

2016

Steven Z. Miller Fellowship in Medical Education, Research Mentor

2015

Junior Faculty, Columbia University T32 Training Program in Lung Science

2015

Faculty Mentor for NIH R25-funded BEST-DP: Biostatistics Enrichment Summer Training Diversity Program

2014

Visiting Professor, Medical College of Wisconsin, Department of Geriatrics and Gerontology, and Division of Critical Care, supported by the Donald W. Reynold’s Foundation Geriatrics Training Program

2014

K23 Career Development Award from the National Institute on Aging

2013

KL2 Scholar Mentored Career Development Award

2010

NCRR UL1 Master’s in Patient Oriented Research Scholarship

2009

New York Presbyterian Hospital Shining Star Employee

2008

Physician of the Year, Greater Baltimore Medical Center, John Hopkins Medicine Affiliate Hospital

2004

Alpha Omega Alpha

2002

United States Fulbright Scholar (Public Health)

1999

Phi Beta Kappa

NATIONAL/INTERNATIONAL COMMITTEES

2020-

Scientist Reviewer, Department of Defense, Clinical Trials Viral Infectious Diseases panel

2019-

Reviewer, National Swiss Science Foundation Sinergia Funding

2019-

Reviewer, Grants for the NIA Early Medical/Surgical Specialists’ Transition to Aging Research (GEMMSTAR) R03

2017-

Member, Data Safety Monitoring Board of the NHLBI-funded NEXIS-trial, a phase III trial of a combined early mobilization and nutritional intervention in adults with the Acute Respiratory Distress Syndrome

COLUMBIA UNIVERSITY MEDICAL CENTER COMMITTEES

2020-

Member, Columbia University Biobank Clinical Phenotyping Working Group

2020-

Faculty Representative for Adult Pulmonary-Critical Care, Columbia COVID Clinical Trials Working Group

2020-

Center Research Faculty Member, NIH-Funded New York Obesity Nutrition Research Center at Columbia University

2016-

Core Faculty, Columbia Aging Center, Columbia University Mailman School of Public Health

Clinical

For appointments: 

To initiate a transfer request, physicians should call 1-800-NYP-STAT which is available 24 hours a day, 7 days a week.

SPECIALTIES

  • Pulmonary Disease Medicine
  • Critical Care Medicine

CLINICAL EXPERTISE

  • General pulmonary medicine
  • Critical Care medicine
  • Prolonged mechanical ventilation and weaning
  • Lung transplantation
  • ECMO

CLINICAL CENTERS

BOARD CERTIFICATIONS

  • Internal Medicine Diplomate, 2007
  • Pulmonary Disease Diplomate, 2010
  • Critical Care Medicine Diplomate, 2011

Research

Contact Information: 

Division of Pulmonary, Allergy, and Critical Care
622 West 168th Street
PH-9 Stem
New York, NY 10032

Contact:
P: (212) 305-6539
E: mrb45@cumc.columbia.edu

RESEARCH INTERESTS

  • Identifying acute and long-term sub-phenotypes of acute respiratory distress syndrome and COVID-19
  • Frailty in survivors of critical illness
  • Palliative care to improve critical illness survivorship
  • Lung Transplantation
  • Critical Illness outcomes

FUNDING

Ongoing Research Support
W81XWH2110217
04/01/2021-03/31/2024
Department of Defense

Title/Goal: Covid-19 Lung Injury, ARDS, and Thrombosis: Acute Disease and Long-term Sub-Phenotypes. We will identify longitudinal sub-phenotypes of adults with COVID acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), and will characterize interstitial and thrombotic lung disease sub-phenotypes in COVID-19 ALI and ARDS survivors.
Role: Co-PI with Christine Garcia, MD, PhD

2020-217820
Silicon Valley Community Foundation
Chan Zuckerberg Initiative
05/01/2020-04/30/2021

Title/Goal: Longitudinal analysis of respiratory immune cells in COVID-19 patients by single cell profiling.
PI: Donna Farber, PhD
Role: Co-I

UL TR001873
07/01/2020-06/30/2025
Integrating Special Populations Research

Role: Co-leader Geriatrics

COVID-19 Clinical Trial
09/01/2020-06/30/2021
Apellis Pharmaceuticals

Title/Goal: A randomized, double-blind, vehicle-controlled, multi-center, parallel-group study of APL-9 (second generation complement-3 inhibitor) in mild to moderate acute respiratory distress syndrome due to COVID-19.
Role: Site PI

Select Previous Research Support
K23AG045560-01A1 (Baldwin)
08/15/2014-08/14/2019
NIA

Frailty, Palliative Needs, and Outcomes in Older Survivors of Critical Illness
To determine whether post-ICU frailty is associated i with symptom burden, disability, and mortality after critical illness, and to pilot a post-ICU palliative care consultation intervention trial among frail ICU survivors
Role: PI

U24 NR014637
07/01/2017 – 06/31/2018

Refinement and Expansion of the Palliative Care Research Cooperative Group (PCRC)
I formatted data from my K23-cohort of older survivors of critical illness for inclusion in this multi-study database that can allow patient-level meta-analysis of palliative care studies.
Role: Subcontract

R25 HL096250 (Begg)
05/15/2015-04/30/2017
BEST-DP: Biostatistics Enrichment Summer Training Diversity Program
Role: Faculty Mentor

KL2 TR000081 (Ginsberg)
07/01/2013-08/14/2014
NIH/NCRR

Title: Improving Critical Illness Survivorship for Older Adults
Role: PI

3P30AG022845-0781 (Reid)
9/01/2011-3/30/2013
NIA

Translational Research Institute for Pain in Later Life
Title: Measuring Frailty and Palliative Needs in Elderly Survivors of Critical Illness
Role: Subcontract Pilot Grant Awardee

 

PUBLICATIONS & CONTRIBUTIONS TO SCIENCE

Using the frailty construct to risk-stratify, endo-phenotype, and discover mechanisms that may represent therapeutic targets in acute respiratory failure survivors. He refined the frailty phenotype measure for use in older adult acute respiratory failure survivors. He showed that post-ICU frailty was a previously unmeasured phenotype that could risk-stratify ICU survivors for long-term mortality better than traditional ICU mortality risk prediction models. He discovered frailty subtypes in acute respiratory failures via a combination of latent class modeling paired with biomarker and proteomics analyses, demonstrating that dysregulated innate immunity and multiple anabolic hormone deficiency may represent therapeutic targets for improving physical recovery. He conducted studies of administrative databases to show that racial/ethnic disparities in mortality among older ICU survivors is due to insurance coverage disparities, independent of frailty and comorbidity.

  1. Baldwin MR, Pollack LR, Friedman RA, Norris SP, Javaid A, O'Donnell MR, et al. Frailty subtypes and recovery in older survivors of acute respiratory failure: a pilot study. Thorax. 2021; 76350-359 PMID: 33298583. PMCID: In-process
  2. Rosenberg BJ, Hirano M, Quinzii CM, Colantuoni E, Needham DM, Lederer DJ, Baldwin MR. Growth differentiation factor-15 as a biomarker of strength and recovery in survivors of acute respiratory failure. Thorax. 2019; 74(11):1099-1101. PMID: 31534031; PMCID: PMC7043788.
  3. Philpotts YF, Ma X, Anderson MR, Hua M, Baldwin MR. Health Insurance and Disparities in Mortality among Older Survivors of Critical Illness: A Population Study. Journal of the American Geriatrics Society. 2019; 67(12):2497-2505. PMID: 31449681; PMCID: PMC7208434.
  4. Baldwin MR, Sell JL, Heyden N, Javaid A, Berlin DA, Gonzalez WC, Bach PB, Maurer MS, Lovasi GS, Lederer DJ. Race, Ethnicity, Health Insurance, and Mortality in Older Survivors of Critical Illness. Critical Care Medicine. 2017; 45(6):e583-e91. PMID: 28333761; PMCID: PMC5433910.
  5. Baldwin MR, Singer JP, Huang D, Sell J, Gonzalez WC, Pollack LR, Maurer MS, D'Ovidio FF, Bacchetta M, Sonett JR, Arcasoy SM, Shah L, Robbins H, Hays SR, Kukreja J, Greenland JR, Shah RJ, Leard L, Morrell M, Gries C, Katz PP, Christie JD, Diamond JM, Lederer DJ. Refining Low Physical Activity Measurement Improves Frailty Assessment in Advanced Lung Disease and Survivors of Critical Illness. Annals of the American Thoracic Society. 2017; 14(8):1270-9. PMID: 28398076; PMCID: PMC5566272.
  6. Baldwin MR, Reid MC, Westlake AA, Rowe JW, Granieri EC, Wunsch H, Dam T, Rabinowitz D, Goldstein N, Maurer MS, Lederer DJ. The feasibility of measuring frailty to predict disability and mortality in older medical-ICU survivors. Journal of Critical Care. 2014; 29(3):401-8. PMID: 24559575; PMCID: PMC4012557.
  7. Baldwin MR, Narain WR, Wunsch H, Schluger NW, Cooke JT, Maurer MS, Rowe JW, Lederer DJ, Bach PB. A prognostic model for 6-month mortality in elderly survivors of critical illness. Chest. 2013;143(4):910-9. PMID: 23632902; PMCID: PMC3616685.

Discovery of immunophenotypes of COVID-19 ARDS and pulmonary fibrosis phenotypes of COVID-19 survivors. He led study design, screening, and enrollment efforts of COVID-19 ARDS patients and survivors, building and analyzing linked databases of critical care clinical data, radiology data, and airway and blood specimen data. He and colleagues have leveraged these deep phenotyping measures to determine the differential effect of body mass index on the risk of acute respiratory failure by age, immune responses that reflect resiliency in COVID ARDS, and risk factors for the development of post-COVID pulmonary fibrosis.

  1. McGroder C, Zhang D, Choudhury M, Salvatore M, D’Souza B, Hoffman E, Wei Y, Baldwin MR*, Garcia CK*. Pulmonary fibrosis four months after COVID-19 is associated with severity of illness and blood leukocyte telomere length. Thorax, 2021. April 29: online ahead of print. *co-senior authors.
  2. Szabo PA, Dogra P, Gray JI, Wells SB, Connors TJ, Weisberg SP, Krupska I, Matsumoto R, Poon MML, Idzikowski E, Morris SE, Pasin C, Yates AJ, Ku A, Chait M, Davis-Porada J, Zhou J, Steinle M, Mackay S, Saqi A, Baldwin MR, Sims PA, Farber DL. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity 2021 54(4):797-814. PMID: 33765436 PMCID: PMC7951561.
  3. Weisberg SP, Connors T, Zhu Y, Baldwin MR, Lin WH, Wontakal S, Szabo PA, Wells SB, Dogra P, Gray JI, Idzikowski E, Bovier F, Davis-Porada J, Matsumoto R, Li Poon MM, Chait MP, Mathieu C, Horvat B, Decimo D, Bitan ZC, La Carpia F, Ferrara SA, Mace E, Milner J, Moscona A, Hod EA, Porotto M, Farber DL. Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19. Nature Immunology. 2021; 22(1):25-31.
  4. Anderson MR, Geleris J, Anderson DR, Zucker J, Nobel YR, Freedberg D, Small-Saunders J, Rajagopalan KN, Greendyk R, Chae SR, Natarajan K, Roh D, Edwin E, Gallagher D, Podolanczuk A, Barr RG, Ferrante AW, Baldwin MR. Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection: A Retrospective Cohort Study. Annals of Internal Medicine 2020. 173(10):782-790. PMID: 32726151; PMCID:PMC7397550.

Determining the clinical-epidemiologic effects of COVID-19 therapeutics and outcomes. He worked with a multidisciplinary team of investigators to create the Columbia COVID-19 critical care database and helped lead important studies in COVID related to the efficacy of hydroxychloroquine, critical care outcomes, and identification of several demographic, clinical, and biomarkers risk factors for more severe disease.

  1. Cummings MJ, Baldwin MR, Abrams D, Jacobson BA, Meyer BJ, Balough EM, Aaron JG, Claassen J, Rabbani LE, Hastie J, Hochman BR, Salazar-Schicchi J, Yip NH, Brodie D, O’Donnell MR. Epidemiology, clinical course, and outcomes, of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763-1770. PMID: 32442528; PMCID: PMC7237188
  2. Argenziano MG, Bruce SL, Slater CL, Tiao JR, Baldwin MR, Barr RG… Natarajan K, Hripcsak G, Chen R. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. British Medical Journal. 2020;369:m1996. PMID: 32471884; PMCID: PMC7256651.
  3. Anderson MR, Bach PB, Baldwin MR. Hospital length of stay for patients with severe COVID-19: Implications for Remdesivir’s value. Pharmacoeconomics. 2020. Dec14;1-3. PMID: 33298583 PMCID: 7734451.
  4. Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, Labella A, Manson DK, Kubin C, Barr RG, Sobieszczyk ME, Schluger NW. Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. The New England Journal of Medicine. 2020; 382:2411-2418; PMID: 32379955 PMCID:PMC7224609.

Development of novel palliative care interventions to improve critical illness survivorship. He showed that the post-ICU frailty phenotype can be used as a predictive enrichment tool to identify patients with symptom clusters that are more likely to persist after hospital discharge. He worked with chaplains to develop a chaplain-led communication-board-guided spiritual care for non-verbal mechanically ventilated patients. This is now available in both board and digital formats, and is used by hospital chaplains across the United States.

  1. Simeone IM, Berning JN, Hua M, Happ MB, Baldwin MR. Training Chaplains to Provide Communication-Board-Guided Spiritual Care for Intensive Care Unit Patients. Journal of Palliative Medicine 2021. 24(2):218-225. PMID: 32639178; PMCID: PMC7840304.
  2. Pollack LR, Goldstein NE, Gonzalez WC, Blinderman CD, Maurer MS, Lederer DJ, Baldwin MR. The Frailty Phenotype and Palliative Care Needs of Older Survivors of Critical Illness. Journal of the American Geriatrics Society. 2017; 65(6):1168-75. PubMed PMID: 28263377; PMCID: PMC5478496.
  3. Berning JB, Poor AD, Buckley SM, Patel KR, Lederer DJ, Goldstein NE, Brodie D, Baldwin MR. A Novel Picture Guide to Improve Spiritual Care and Reduce Anxiety in Mechanically Ventilated Intensive Care Unit Adults. Annals of the American Thoracic Society. 2016; 13(8):1333-1342. PMID: 27097049; PMCID: PMC5478496.
  4. Baldwin MR, Wunsch H, Reyfman PA, Narain WR, Blinderman CD, Schluger NW, Reid MC, Maurer MS, Goldstein N, Lederer DJ, Bach P. High Burden of Palliative Needs among Older ICU Survivors Transferred to Post-Acute Care Facilities: A Single Center Study. Annals of the American Thoracic Society. 2013; 10(5): 458-65. PMID: 23987743; PMCID: PMC3960912.

Determining the effects of frailty on lung transplantation outcomes. He has shown that factors related to frailty (skeletal muscle adiposity, hypoalbuminemia, donor age) are associated with mortality after lung transplantation. Collectively, these studies suggest that the current Lung Allocation Score system may be improved by using frailty measurements to improve lung transplantation candidacy and donor selection.

  1. Anderson MR, Easthausen I, Gallagher G, Udupa J, Tong Y, Torigian D, Diamond JM, Porteous MK, Palmer SM, Snyder LD, Benvenuto L, Aversa M, Arcasoy S, Greenland JR, Hays SR, Kukreja J, Cantu E, Kim JS, Gallagher D, Baldwin MR, Barr RG, Lederer DJ, Christie JD, Singer JP. Skeletal muscle adiposity and outcomes in candidates for lung transplantation: a lung transplant body composition cohort study. Thorax 2020. 75(9):801-804. PMID: 32482837; PMCID: In-Process
  2. Layton AM, Armstrong HF, Baldwin MR, Podolanczuk AJ, Pieszchata NM, Singer JP, Arcasoy SM, Meza KS, D'Ovidio F, Lederer DJ. Frailty and maximal exercise capacity in adult lung transplant candidates. Respiratory Medicine. 2017;131:70-6. PMID: 28947046; PMCID: PMC5749422.
  3. Baldwin MR, Peterson ER, Easthausen I, Quintanilla I, Colago E, Sonett JR, D'Ovidio F, Costa J, Diamond JM, Christie JD, Arcasoy SM, Lederer DJ. Donor Age and Early Graft Failure After Lung Transplantation: A Cohort Study. American Journal of Transplantation. 2013 Oct;10:2685-95. PMID: 24034167; PMCID: PMC4157369.
  4. Baldwin MR, Arcasoy SM, Shah A, Schulze PC, Sze J, Sonett JR, Lederer DJ. Hypoalbuminemia and early mortality after lung transplantation: a cohort study. American Journal of Transplantation. 2012;12(5):1256-67. PMID: 22335491; PMCID: PMC3628840.

Other critical care outcomes research. He assists mentees and other Columbia University critical care faculty with study design and analytic methods for critical care outcomes research, including repeated measures analysis, propensity matching, nonlinear regression, competing risk regression, machine learning prediction modeling, and implementation science methods.

  1. Yarnell CJ, Abrams D, Baldwin MR, Brodie D, Fan E, Ferguson ND, et al. Clinical trials in critical care: can a Bayesian approach enhance clinical and scientific decision making? Lancet Respiratory Medicine. 2021; 9(2):207-216. PMID: 33227237.
  2. Short B, Serra A, Tariq A, Moitra V, Brodie D, Patel S, Baldwin MR, Yip NH. Implementation of lung protective ventilation order to improve adherence to low tidal volume ventilation: A RE-AIM evaluation. Journal of Critical Care. 2020 Sep 2. Online ahead of print. PMID: 33004237
  3. Peters A, Caroline M, Zhao H, Baldwin MR, Forfia PR, Tsai EJ. Initial Right Ventricular Dysfunction Severity Identifies Severe Peripartum Cardiomyopathy Phenotype With Worse Early and Overall Outcomes: A 24-Year Cohort Study. Journal of the American Heart Association. 2018; 7(9):e008378. PMID: 29686029; PMCID:PMC6015280.
  4. Gannon W, Lederer DJ, Biscotti M, Javaid A, Patel N, Brodie D, Bacchetta M, Baldwin MR. Outcomes and Mortality Prediction Model of Critically Ill Adults With Acute Respiratory Failure and Interstitial Lung Disease. Chest. 2018; 153(6):1387-1395. PMID: 29353024; PMCID: 6026289.
  5. Abrams D*, Baldwin MR*, Campion M, Agerstrand C, Eisenberger A, Bacchetta M, Brodie D. Thrombocytopenia and extracorporeal membrane oxygenation in adults with acute respiratory failure: a cohort study. Intensive Care Medicine. 2016; 42(5):844-52. PMID: 27007099.
    *Co-primary authors
  6. Kato TS, Cheema FH, Yang J, Kawano Y, Takayama H, Naka Y, Farr M, Lederer DJ, Baldwin MR, Jin Z, Homma S, Mancini DM, Schulze PC. Preoperative serum albumin levels predict 1-year postoperative survival of patients undergoing heart transplantation. Circulation Heart Failure. 2013; 6(4):785-91. PMID: 23674381 PMCID: 4074373.

Developing new models of training and education in gerontology for specialists. He has collaborated with other medicine specialists to develop a peer mentorship program to support gerontologic research, and have conducted studies with medical students to identify distressing aspects with the care of older adults with the goal of developing new threads of geriatrics and gerontology education for the medical school curriculum.

  1. Perni S, Pollack LR, Gonzalez WC, Dzeng E, Baldwin MR. Moral distress and burnout in caring for older adults during medical school training. BMC Medical Education. 2020; 20(1):84. PMID: 32293416; PMCID:PMC7092500.
  2. Masterson Creber RM, Baldwin MR, Brown PJ, Rao MK, Goyal P, Hummel S, Dodson JA, Helmke S, Maurer MS. Facilitated Peer Mentorship to Support Aging Research: A RE-AIM Evaluation of the CoMPAdRE Program. Journal of the American Geriatrics Society. 2019 Apr;67(4):804-810. PMID: 30693950. PMCID: PMC6554736.

Determining the role of micronutrient deficiency on tuberculosis risk and lung function. As a medical student, Fulbright scholar in Public Health, and as a resident physician, he worked with Johns Hopkins School of Public Health investigators to show that vitamin D deficiency from lack of sunlight exposure is a modifiable risk factor that may explain seasonal variation in Tuberculosis, and that it can be used to identify individuals at-risk for Tuberculosis. He and colleagues also showed that vitamin A supplementation before, during, and after pregnancy improves lung function in offspring. I still collaborate with these investigators, offering input on causal inference and clinical prediction modeling for ancillary studies of these cohorts.

  1. Saunders MJ, Wingfield T, Datta S, Montoya R, Ramos E, Baldwin MR, Tovar MA, Evans BEW, Gilman RH, Evans CA. A household-level score to predict the risk of tuberculosis among contacts of patients with tuberculosis: a derivation and external validation prospective cohort study. Lancet Infectious Diseases. 2020; 20(1):110-122. PMID: 31449681; PMCID: PMC7208434
  2. Saunders MJ, Tovar MA, Collier D, Baldwin MR, Montoya R, Valencia TR, Friedland JS, Gilman RH, Evans CA. Active and passive case finding in tuberculosis-affected households: a 10-year prospective cohort study, Peru. Lancet Infectious Diseases. 2019; 19(5):519-528. PMID: 30910427; PMCID: PMC6554736
  3. Saunders MJ, Wingfield T, Tovar MA, Baldwin MR, Datta S, Zevallos K, Montoya R, Valencia TR, Friedland JS, Moulton LH, Gilman RH, Evans CA. A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: a prospective derivation and external validation cohort study. The Lancet Infectious Diseases. 2017; 17(11):1190-1199. PMID: 28827142.
  4. Wingfield T, Schumacher SG, Gurinder S, Tovar M, Zevallos K, Baldwin MR, Montoya R, Ramos E, Jongkaewwattana C, Sampson B, Boccia D, Lewis LJ, Friedland JS, Gilman RH, Evans CE. Tuberculosis, sunlight, and vitamin D seasonality. Journal of Infectious Diseases, 2014; 210(5):774-783. PMID: 24596279; PMCID: PMC4130318
  5. Checkley W, West KP, Jr., Wise RA, Baldwin MR, Wu L, LeClerq SC, Christian P, Katz J, Tielsch JM, Khatry S, Sommer A. Maternal vitamin A supplementation and lung function in offspring. New England Journal of Medicine. 2010; 362(19):1784-1794. PMID: 20463338.
  6. Baldwin MR, Checkley W, Wise RA, Khatry SK, LeClerq SC, West KP, Jr. A cleaning and calibration method for the SpiroPro portable spirometer's pneumotachometer tube in a remote field study. Respiratory Care. 2010; 55(4):443-452. PMID: 20406512.
  7. Baldwin MR, Yori PP, Ford C, Moore DA, Gilman RH, Vidal C, Ticona E, Evans CA. Tuberculosis and nutrition: disease perceptions and health seeking behavior of household contacts in the Peruvian Amazon. International Journal of Tuberculosis and Lung Disease. 2004; 8(12):1484-1491. PMID: 15636496; PMCID: PMC2912521.

BOOK CHAPTERS AND INVITED REVIEWS

  1. Nalbandian A, Aakriti G, Madhavan M, McGroder C, Stevens J, Cook J, Nordvig A, Shalev D, Sehrawat T, Ahluwalia N, Bikdeli B, Dietz D, Der-Nigoghossian c, Liyanage-Don N, Rosner G, Bernstein E, Mohan S, Beckley A, Seres D, Choueiri T, Uriel N, Ausiello J, Accili D, Freedberg D, Baldwin M, Schwartz A, Brodie D, Garcia C, Elkind M, Connors J, Bilezikian J, Landry D, Wan E. Post-acute COVID-19 Syndrome. Nature Medicine. 2021; 27(4):601-615.
  2. Paul JA, Whittington RA, Baldwin MR. Critical Illness and the Frailty Syndrome: Mechanisms and Potential Therapeutic Targets. Anesth Analg. 2020; 130(6):1545-1555. PMID: 32384344; PMCID: In-Process.
  3. Singer JP, Lederer DJ, Baldwin MR. Frailty in Pulmonary and Critical Care Medicine. Annals of the American Thoracic Society. 2016; 13(8):1333-1342. PMID: 27097049; PMCID: PMC5021078.
  4. Baldwin MR. Measuring and predicting long-term outcomes in older survivors of critical illness. Minerva Anestesiologica. 2015; 81(6):650-661. PMID: 24923682; PMCID 4375061.
  5. Baldwin MR and Wunsch H. (2014) Mortality after critical illness. In: Stevens RD, Hart N, and Herridge M (Eds). The legacy of critical illness: A textbook of post-ICU medicine (pp. 18-38). Oxford: Oxford University Press.
  6. Baldwin MR and Wanner TJ. Part IV: Rapid References in The Osler Medical Handbook, 2nd Ed. Philadelphia: Saunders Elsevier, 2005, 1007-1016.

Complete List of Published Work in MyBibliography

http://www.ncbi.nlm.nih.gov/sites/myncbi/matthew.baldwin.1/bibliography/45834830/public/?sort=date&direction=descending 

 

BALDWIN LABORATORY PAGE

Division of Pulmonary, Allergy, and Critical Care Baldwin Laboratory